Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Spain
Clinical trial register · European Union · CTIS

Clinical Trials in Spain, 2026

The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.

Download CSV
Source: EMA Clinical Trials Information System (CTIS). Showing the 2554 most recently authorised of 12905 total CTIS records — a stated recency window, not the full historical archive. Synced 21 Nov 2026, 03:17 UTC
2554
Shown in this register
most recently authorised
12,905
Total on CTIS
full historical archive
780
Phase III
within the shown window
Top member states
Spain 1064 France 921 Germany 904 Italy 766 Poland 624 Netherlands 546

Trials with a site in Spain

1064 of 2554 shown studies
Download
Phase
Study
Lead sponsor
Area
Member states
Decision
Phase III
Amgen Inc.
Nutritional and Metabolic Diseases
Germany, Spain, Poland
19/11/2026
Phase III
Rapport Therapeutics Inc.
Nervous System Diseases
Denmark, Czechia, Lithuania, Hungary, Portugal, Poland, Ireland, Greece, Germany, Slovakia, Spain, Finland, Netherlands, Sweden
18/11/2026
Phase II
JJP BIOLOGICS Sp. z o.o.
Female Urogenital Diseases and Pregnancy Complications
Germany, Belgium, Poland, Sweden, Spain, Lithuania
17/11/2026
Phase II
AbbVie Deutschland GmbH & Co. KG
Digestive System Diseases
Netherlands, Belgium, Greece, Spain, Lithuania, Germany, Czechia, Italy, Slovakia, Ireland, Poland, Portugal, Sweden, Hungary, France
17/11/2026
Phase I
Laboratorios Normon S.A.
Not possible to specify
Spain
17/11/2026
Phase III
Azafaros B.V.
Nutritional and Metabolic Diseases
Sweden, France, Germany, Spain, Portugal
16/11/2026
Phase II
AbbVie Deutschland GmbH & Co. KG
Immune System Diseases
France, Netherlands, Belgium, Spain, Poland, Ireland, Germany, Italy, Hungary, Slovakia, Sweden, Czechia, Lithuania, Greece, Portugal
16/11/2026
Phase III
Calcilytix Therapeutics Inc.
Hormonal diseases
France, Italy, Spain, Czechia, Netherlands, Denmark, Germany, Hungary, Poland
16/11/2026
Phase IV
CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS
Neoplasms
Spain
12/11/2026
Phase III
Rapport Therapeutics Inc.
Nervous System Diseases
Netherlands, Austria, Czechia, Belgium, Slovakia, Finland, Poland, Spain, Ireland, Sweden, Germany, Hungary, Denmark, Italy, Portugal
11/11/2026
Phase III
Merck Sharp & Dohme LLC
Eye Diseases
Portugal, Austria, Spain, Czechia, Hungary, France, Poland
11/11/2026
Phase II
Fundacion De La Comunitat Valenciana Para La Gestion Del Instituto De Investigacion Sanitaria Y Biomedica De Alicante
Not possible to specify
Spain
11/11/2026
Phase I
A Phase 1b, open-label study in hematologic support–dependent HHT (TERRA study)
2026-527885-60-00Hereditary hemorrhagic telangiectasia (HHT)
Tectonic Operating Company Inc.
Cardiovascular Diseases
Spain
11/11/2026
Phase III
Novartis Pharma AG
Immune System Diseases
Germany, Italy, Spain, Portugal, Netherlands, Belgium, Hungary
10/11/2026
Phase III
Seismic Pharmaceuticals Operations LLC
Cardiovascular Diseases
Spain, Portugal, Bulgaria, Italy, Poland, Romania, Czechia, Greece
10/11/2026
Phase III
F. Hoffmann-La Roche AG
Nutritional and Metabolic Diseases
Germany, Hungary, Poland, Greece, Portugal, Sweden, Spain
10/11/2026
Phase II
UCB Biopharma
Respiratory Tract Diseases
Poland, Ireland, Belgium, Portugal, Italy, France, Spain, Bulgaria, Germany
10/11/2026
Phase III
Novartis Pharma AG
Neoplasms
Czechia, Portugal, Germany, Austria, Poland, Belgium, Spain, Netherlands, Italy, France, Slovakia
10/11/2026
Phase III
Glaxosmithkline Research & Development Limited
Male Urogenital Diseases
Germany, Spain, Italy, France, Netherlands, Poland
10/11/2026
Phase I
Evexta Bio
Neoplasms
France, Spain
09/11/2026
Phase III
Centessa Pharmaceuticals UK Limited
Nervous System Diseases
Italy, Spain, Germany, Finland, Belgium, France, Poland, Austria
09/11/2026
Phase II
Medica Scientia Innovation Research S.L.
Neoplasms
Spain, Germany, Austria
09/11/2026
Phase III
F. Hoffmann-La Roche AG
Nutritional and Metabolic Diseases
Hungary, Ireland, Germany, Spain, Romania, Denmark, Poland, France, Italy
09/11/2026
Phase I
CRISPR Therapeutics AG
Nervous System Diseases
Germany, Austria, Spain, Belgium
09/11/2026
Phase II
UCB Biopharma
Respiratory Tract Diseases
Italy, Netherlands, Poland, Belgium, Spain, France, Czechia, Bulgaria, Germany, Slovakia
09/11/2026
Phase IV
Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Diagnosis
Spain
06/11/2026
Phase III
Priovant Therapeutics Inc.
Skin and Connective Tissue Diseases
Belgium, Czechia, Poland, Netherlands, France, Italy, Spain, Hungary, Germany
06/11/2026
Phase III
Nutricion Medica S.L.
Cardiovascular Diseases
Spain
05/11/2026
Phase II
Scholar Rock Inc.
Musculoskeletal Diseases
Italy, France, Spain
05/11/2026
Phase II
Contera Pharma A/S
Nervous System Diseases
Poland, Italy, Spain
05/11/2026
Phase III
Priovant Therapeutics Inc.
Skin and Connective Tissue Diseases
Germany, Austria, Netherlands, Spain, Belgium, Italy, France
04/11/2026
Phase I/II
Fundacion Instituto De Investigacion Sanitaria De Navarra
Immune System Diseases
Spain
04/11/2026
Phase III
Hunan Mabgeek Biotech Co. Ltd.
Skin and Connective Tissue Diseases
Czechia, Spain, Poland
04/11/2026
Phase III
Nektar Therapeutics
Skin and Connective Tissue Diseases
Lithuania, Slovakia, Bulgaria, Greece, Czechia, Poland, Spain, Belgium, Germany
03/11/2026
Phase II
Novartis Pharma AG
Immune System Diseases
Italy, Netherlands, Poland, Germany, Spain, France
02/11/2026
Phase I
Eli Lilly & Co.
Neoplasms
Italy, France, Denmark, Poland, Spain, Germany
02/11/2026
Phase II
Regeneron Pharmaceuticals Inc.
Nutritional and Metabolic Diseases
Spain, Italy
30/10/2026
Phase III
Lumos Pharma LLC
Hormonal diseases
Romania, Poland, Italy, France, Spain
30/10/2026
Phase III
Sanofi-Aventis Recherche & Developpement
Nervous System Diseases
Hungary, Belgium, Lithuania, Spain, France, Germany, Netherlands, Poland, Denmark, Slovakia, Italy, Austria, Bulgaria, Portugal, Greece, Czechia, Sweden
30/10/2026
Phase II
Bicara Therapeutics Inc.
Neoplasms
Netherlands, Spain, France, Italy, Belgium, Poland, Germany
30/10/2026
Phase I
Grupo Cooperativo De Estudio Y Tratamiento De Las Leucemias Agudas Y Mielodisplasias
Neoplasms
Spain
28/10/2026
Phase I
Argenx
Musculoskeletal Diseases
Slovenia, Latvia, Denmark, Germany, Belgium, Norway, Spain, Poland, Lithuania, Italy, France, Netherlands
27/10/2026
Phase II
Verastem Inc.
Neoplasms
France, Spain, Germany, Italy, Belgium
27/10/2026
Phase III
Glaxosmithkline Research & Development Limited
Neoplasms
Czechia, Poland, Austria, Italy, Spain, Sweden, Germany, France, Netherlands, Portugal, Finland, Greece
27/10/2026
Phase II
Agomab Spain S.L.U.
Respiratory Tract Diseases
Poland, France, Belgium, Italy, Spain, Portugal, Netherlands, Germany
27/10/2026
Phase II
Asac Pharmaceutical Inmunology S.A.
Diagnosis
Spain
27/10/2026
Phase III
Celcuity Inc.
Neoplasms
Finland, Bulgaria, Portugal, Germany, Greece, Romania, Poland, Hungary, Czechia, Italy, Denmark, Belgium, France, Spain
27/10/2026
Phase I
A Study of RO7821657 in Participants with Solid Tumors
2026-526150-14-00Advanced and/or Metastatic Solid Tumors
F. Hoffmann-La Roche AG
Neoplasms
France, Denmark, Spain
27/10/2026
Phase II
F. Hoffmann-La Roche AG
Nervous System Diseases
Spain, Belgium, Denmark, France, Poland, Italy, Germany, Ireland
27/10/2026
Phase I/II
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Neoplasms
Germany, Spain, France, Poland, Belgium, Netherlands
26/10/2026
Phase III
Takeda Development Center Americas Inc.
Nervous System Diseases
Spain, France, Italy
23/10/2026
Phase III
Ohb Pediatrics Limited
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Spain, Poland, Germany, Netherlands, Italy
23/10/2026
Phase III
Novo Nordisk A/S
Nutritional and Metabolic Diseases
Portugal, Bulgaria, Germany, Croatia, Hungary, Czechia, Romania, Spain, Italy, Denmark, Slovakia, Greece, Poland
23/10/2026
Phase III
Novartis Pharma AG
Immune System Diseases
Germany, Austria, Poland, Spain, Italy, France
23/10/2026
Phase II
University Of Leicester
Respiratory Tract Diseases
Spain, Netherlands, Italy, Denmark
22/10/2026
Phase I
Bioavailability and Bioequivalence Study of Ziftomenib in Participants with Relapsed/Refractory AML or MDS
2025-524332-19-00Acute Myeloid Leukemia and Myelodysplastic Syndrome
Kura Oncology Inc.
Neoplasms
Spain, Italy, France
21/10/2026
Phase III
Novo Nordisk A/S
Nutritional and Metabolic Diseases
Croatia, Spain, Portugal, Hungary, Bulgaria, Poland
21/10/2026
Phase III
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Respiratory Tract Diseases
Belgium, France, Netherlands, Finland, Italy, Spain, Germany, Poland, Austria
21/10/2026
Phase II
F. Hoffmann-La Roche AG
Nervous System Diseases
Germany, Italy, Netherlands, Poland, France, Ireland, Spain, Austria
21/10/2026
Phase I/II
Camp4 Therapeutics Corp.
Nervous System Diseases
France, Spain, Italy, Netherlands, Poland, Germany
20/10/2026
Phase I/II
SOTIO Biotech a.s.
Neoplasms
Czechia, Spain, France, Belgium
20/10/2026
Phase III
Bristol-Myers Squibb Services Unlimited Company
Mental Disorders
Romania, Bulgaria, Poland, Denmark, Spain
20/10/2026
Phase III
AstraZeneca AB
Musculoskeletal Diseases
Netherlands, Belgium, Bulgaria, Romania, Italy, Germany, Austria, Spain, Portugal, Greece, Czechia, Poland, France
20/10/2026
Phase III
Swedish Orphan Biovitrum AB (publ)
Immune System Diseases
Italy, Finland, France, Germany, Spain
20/10/2026
Phase III
Newave Pharmaceutical Inc.
Hemic and Lymphatic Diseases
Poland, Germany, Spain, Czechia, Italy, France
20/10/2026
Phase III
Glaxosmithkline Research & Development Limited
Immune System Diseases
France, Belgium, Italy, Spain, Austria, Germany, Netherlands, Portugal, Poland, Greece
19/10/2026
Phase II
European Organisation For Research And Treatment Of Cancer
Neoplasms
Slovenia, Spain, Germany, France, Austria, Netherlands, Italy, Greece
19/10/2026
Phase IV
Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Not possible to specify
Spain
19/10/2026
Phase I/II
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Therapeutics
Spain
19/10/2026
Phase III
Novo Nordisk A/S
Hemic and Lymphatic Diseases
France, Italy, Greece, Poland, Spain, Denmark, Germany
19/10/2026
Phase II
Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Neoplasms
Spain
19/10/2026
Phase III
AstraZeneca AB
Cardiovascular Diseases
France, Germany, Austria, Poland, Romania, Italy, Greece, Bulgaria, Spain
19/10/2026
Phase II
Ns Pharma Inc.
Respiratory Tract Diseases
Italy, Greece, Portugal, France, Belgium, Germany, Spain
16/10/2026
Phase III
Fundacio Sant Joan De Deu
Female Urogenital Diseases and Pregnancy Complications
Spain
16/10/2026
Phase III
Janssen Cilag International
Immune System Diseases
Hungary, Spain, Germany, Poland
15/10/2026
Phase II
Novartis Pharma AG
Immune System Diseases
Portugal, Bulgaria, Belgium, Spain, Denmark, France, Slovakia, Poland, Hungary, Italy, Netherlands, Germany, Austria
15/10/2026
Phase II
Biogen Idec Research Limited
Nutritional and Metabolic Diseases
Italy, Spain
15/10/2026
Phase III
Eli Lilly & Co.
Nutritional and Metabolic Diseases
Spain, Poland, France, Italy, Germany, Czechia, Romania, Hungary
15/10/2026
Phase I
A Study of ASP1002 in Adults for Treatment of Solid Tumors
2024-512410-18-00Metastatic or Locally Advanced Solid Tumors
Astellas Pharma Global Development Inc.
Neoplasms
France, Spain
15/10/2026
Phase III
Pfizer Inc.
Female Urogenital Diseases and Pregnancy Complications
France, Spain, Italy, Germany
15/10/2026
Phase I
Asociacion Instituto De Investigacion Sanitaria Biobizkaia
Hemic and Lymphatic Diseases
Spain
14/10/2026
Phase I
Iteria Biopharma S.L.
Neoplasms
Spain
13/10/2026
Phase I
Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino Jesus
Nervous System Diseases
Spain
13/10/2026
Phase I
Consorci Mar Parc De Salut De Barcelona
Not possible to specify
Spain
13/10/2026
Phase I
A Study of ARC-02 in B-cell NHL
2026-525606-35-00B-cell Non Hodgkins Lymphoma (NHL)
Taiho Oncology Inc.
Neoplasms
Spain, Poland, France, Italy
13/10/2026
Phase III
Glaxosmithkline Research & Development Limited
Nutritional and Metabolic Diseases
Netherlands, Germany, Austria, France, Spain, Italy, Bulgaria, Poland, Belgium, Greece
13/10/2026
Phase II
Glaxosmithkline Research & Development Limited
Digestive System Diseases
Spain, Denmark, Italy, Poland, France, Germany, Greece
12/10/2026
Phase III
Ferrer Internacional S.A., Prilenia Therapeutics B.V.
Nervous System Diseases
Spain, Italy, Portugal, Poland, France, Netherlands, Germany, Belgium, Czechia
12/10/2026
Phase III
Glaxosmithkline Research & Development Limited
Nutritional and Metabolic Diseases
Netherlands, Greece, Austria, Spain, Italy, France, Belgium, Bulgaria, Germany, Poland
12/10/2026
Phase II
Novartis Pharma AG
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
France, Italy, Bulgaria, Slovakia, Finland, Spain
12/10/2026
Phase III
Revolution Medicines Inc.
Neoplasms
Austria, Netherlands, Germany, Sweden, Spain, Belgium, Norway, France, Italy
12/10/2026
Phase I
JNJ-98768111 for Advanced Prostate Cancer
2026-525894-37-00Advanced prostate cancer
Janssen Cilag International
Neoplasms
Spain
09/10/2026
Phase II
Almirall S.A.
Immune System Diseases
Poland, Spain, Hungary, Bulgaria
09/10/2026
Phase II
Ns Pharma Inc.
Respiratory Tract Diseases
France, Germany, Poland, Italy, Belgium, Spain, Greece
08/10/2026
Phase III
Takeda Development Center Americas Inc.
Hemic and Lymphatic Diseases
Italy, Austria, Greece, Ireland, Bulgaria, Poland, Sweden, Belgium, Germany, Spain, Czechia, France, Romania, Hungary
08/10/2026
Phase III
Inmunotek S.L.
Immune System Diseases
Spain
08/10/2026
Phase III
Vor Biopharma Inc.
Immune System Diseases
Poland, Spain, Hungary, Italy, Netherlands, Romania, Belgium, France, Bulgaria, Germany
06/10/2026
Phase III
Harmony Biosciences Management Inc.
Nervous System Diseases
France, Germany, Belgium, Spain, Italy, Poland
06/10/2026
Phase I/II
Antares Therapeutics Inc.
Neoplasms
Netherlands, Spain, France, Italy
05/10/2026
Phase III
Vivus B.V., Vivus LLC
Respiratory Tract Diseases
Italy, France, Czechia, Poland, Latvia, Germany, Spain
05/10/2026
Phase III
AstraZeneca AB
Nutritional and Metabolic Diseases
Spain, Poland, Slovakia, Germany
05/10/2026
Phase II
Argenx
Not possible to specify
Spain, Poland, Czechia, Belgium, Italy
05/10/2026
Phase III
Zydus Therapeutics Inc.
Digestive System Diseases
Ireland, Greece, Estonia, Netherlands, Bulgaria, Slovakia, Poland, Latvia, Croatia, Spain, France, Italy
05/10/2026
Phase III
Novartis Pharma AG
Immune System Diseases
Austria, Portugal, Slovakia, Italy, Poland, Hungary, Spain, Czechia, France, Netherlands, Germany
05/10/2026
Phase II
Merck Sharp & Dohme LLC
Neoplasms
Belgium, Spain, Denmark, Italy, France
05/10/2026
Phase I/II
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Neoplasms
Poland, France, Belgium, Germany, Netherlands, Spain
05/10/2026
Phase III
Impact of Semaglutide in Liver Transplant Candidates with Obesity (SOMAL Study): A Prospective Randomized Study.
2026-526953-32-00Arterial hypertension, Type 2 diabetes mellitus, Obesity, D…
Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
Surgical Procedures, Operative
Spain
02/10/2026
Phase IV
Consorci Mar Parc De Salut De Barcelona
Bacterial Infections and Mycoses
Spain
02/10/2026
Phase IV
Crohn’s disease Longitudinal Evaluation of Anti-fibrotic Response to UPadacitinib
2025-523038-16-00Crohn’s disease with ileal stricturing complication
UZ Leuven
Investigative Techniques
Spain, Germany, Belgium
01/10/2026
Phase III
Pfizer Inc.
Respiratory Tract Diseases
Spain, Poland
01/10/2026
Phase II
Consorci Mar Parc De Salut De Barcelona
Neoplasms
Spain
01/10/2026
Phase I/II
Modex Therapeutics Inc.
Hemic and Lymphatic Diseases
Spain, Italy
01/10/2026
Phase III
Institut D Investigacio Sanitaria Pere Virgili
Cardiovascular Diseases
Spain
30/09/2026
Phase I
Bicara Therapeutics Inc.
Neoplasms
Spain, France
30/09/2026
Phase I
A phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors
2024-518348-19-00Advanced Breast cancer (HER2+, HR+/HER2-negative or TNBC), …
Novartis Pharma AG
Neoplasms
France, Italy, Spain, Portugal, Germany, Belgium
29/09/2026
Phase III
Regeneron Pharmaceuticals Inc.
Nutritional and Metabolic Diseases
Romania, Poland, Hungary, Germany, Spain
29/09/2026
Phase III
Insmed Inc.
Cardiovascular Diseases
Germany, Hungary, Belgium, France, Italy, Sweden, Austria, Poland, Lithuania, Spain, Romania, Greece
29/09/2026
Phase III
F. Hoffmann-La Roche AG
Nervous System Diseases
Spain, Denmark
29/09/2026
Phase III
Regeneron Pharmaceuticals Inc.
Cardiovascular Diseases
Portugal, Germany, Italy, Czechia, Austria, Spain, Belgium, Netherlands, Poland, Sweden, Greece, Latvia, Hungary, Bulgaria, Romania
29/09/2026
Phase III
Regeneron Pharmaceuticals Inc.
Cardiovascular Diseases
Spain, Bulgaria, Hungary, Poland, Romania, Sweden, Germany, Italy, Latvia, Netherlands, Portugal
29/09/2026
Phase II
Expedition Therapeutics Inc.
Respiratory Tract Diseases
Italy, Germany, Spain, Poland, Czechia, Romania, Hungary, Denmark, Bulgaria
29/09/2026
Phase III
Regeneron Pharmaceuticals Inc.
Hemic and Lymphatic Diseases
Spain, Slovakia, Hungary, Czechia, Romania, Estonia, Austria, France, Belgium, Sweden, Italy, Latvia, Poland, Bulgaria, Greece, Germany, Denmark, Lithuania, Netherlands
29/09/2026
Phase III
Crinetics Pharmaceuticals Inc.
Not possible to specify
Sweden, Austria, Spain, Poland, Netherlands, Italy, Germany, France
28/09/2026
Phase III
Kardigan Inc.
Cardiovascular Diseases
Poland, Sweden, Belgium, France, Spain, Hungary, Denmark, Italy, Netherlands
28/09/2026
Phase III
Atsena Therapeutics Inc.
Eye Diseases
Italy, Germany, Spain, Netherlands, France, Belgium
28/09/2026
Phase III
Dianthus Therapeutics Inc.
Immune System Diseases
Czechia, Portugal, Austria, Bulgaria, Germany, France, Latvia, Poland, Italy, Spain, Denmark
28/09/2026
Phase I
A Study to Learn About the Study Medicine Called PF-08032562 in People with Advanced or Metastatic Solid Tumors
2025-524387-38-00metastatic/advanced breast cancer (BC) and colorectal cance…
Pfizer Inc.
Neoplasms
France, Spain
25/09/2026
Phase II
Alianza Multidisciplinar Para La Investigacion De Los Tumores Genitourinarios Guard
Neoplasms
Spain
24/09/2026
Phase III
GlaxoSmithKline Biologicals
Virus Diseases
Belgium, Germany, Finland, Spain
24/09/2026
Phase III
AstraZeneca AB
Neoplasms
Italy, Poland, Spain, France, Germany
23/09/2026
Phase II
Oryzon Genomics S.A.
Behavior and Behavior Mechanisms
Spain
23/09/2026
Phase III
Almirall S.A.
Skin and Connective Tissue Diseases
Poland, Germany, Portugal, France, Spain, Denmark
22/09/2026
Phase II
Agomab Spain S.L.U.
Digestive System Diseases
France, Germany, Poland, Spain, Czechia, Denmark, Austria, Italy, Belgium, Netherlands
21/09/2026
Phase III
Amgen Inc.
Nutritional and Metabolic Diseases
Czechia, Spain, Poland, Denmark, Germany, Italy, Belgium, Finland
21/09/2026
Phase III
Novo Nordisk A/S
Hemic and Lymphatic Diseases
France, Netherlands, Spain, Italy
21/09/2026
Phase III
Glaxosmithkline Research & Development Limited
Neoplasms
Denmark, Netherlands, Italy, Spain, France, Portugal, Greece, Poland, Germany, Belgium, Norway, Czechia
21/09/2026
Phase II
Oruka Therapeutics Inc.
Skin and Connective Tissue Diseases
Spain, Germany
21/09/2026
Phase II
AnaCardio AB
Cardiovascular Diseases
Czechia, Slovakia, Spain, Bulgaria, Netherlands, Italy, Poland, Germany, Sweden, Hungary
21/09/2026
Phase I
Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal
Immune System Diseases
Spain
18/09/2026
Phase III
Celea Therapeutics Inc.
Respiratory Tract Diseases
Greece, Italy, Czechia, France, Portugal, Denmark, Spain, Poland, Germany, Romania, Belgium, Netherlands
18/09/2026
Phase IV
Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz
Musculoskeletal Diseases
Spain
18/09/2026
Phase II
Corvus Pharmaceuticals Inc.
Skin and Connective Tissue Diseases
Italy, Czechia, Germany, Poland, Spain, Bulgaria
18/09/2026
Phase III
Genmab A/S
Neoplasms
Czechia, Netherlands, Lithuania, Ireland, Finland, Hungary, Spain, Greece, Italy, France, Germany, Poland
18/09/2026
Phase III
Aura Biosciences Inc.
Neoplasms
Austria, Netherlands, Belgium, Czechia, Spain, France, Germany, Italy
17/09/2026
Phase III
Pharmacosmos A/S
Neoplasms
Czechia, Greece, France, Belgium, Italy, Spain, Germany
17/09/2026
Phase III
Novo Nordisk A/S
Cardiovascular Diseases
Denmark, Czechia, Greece, France, Italy, Germany, Spain, Poland, Netherlands, Bulgaria
16/09/2026
Phase III
Amgen Inc.
Digestive System Diseases
Belgium, Germany, Hungary, Czechia, Bulgaria, France, Netherlands, Italy, Poland, Greece, Portugal, Spain
16/09/2026
Phase I
Novartis Pharma AG
Neoplasms
Germany, France, Netherlands, Spain, Italy
15/09/2026
Phase I
Detection of rEPO using Dried Blood Spot (DBS)
2026-526613-29-01healthy participants
Consorci Mar Parc De Salut De Barcelona
Not possible to specify
Spain
15/09/2026
Phase II
H. Lundbeck A/S
Nervous System Diseases
Czechia, France, Spain, Poland, Italy, Germany, Sweden
15/09/2026
Phase II
Novartis Pharma AG
Skin and Connective Tissue Diseases
Bulgaria, Spain, France, Italy, Germany
14/09/2026
Phase IV
Urogen Pharma Ltd.
Neoplasms
Estonia, Romania, Spain, Bulgaria, Latvia
11/09/2026
Phase II
Enveda Therapeutics Inc.
Skin and Connective Tissue Diseases
Germany, Czechia, Bulgaria, Poland, Spain
10/09/2026
Phase IV
Sanofi-Aventis Recherche & Developpement
Respiratory Tract Diseases
France, Spain, Germany, Italy
09/09/2026
Phase III
Pfizer Inc.
Nutritional and Metabolic Diseases
Spain, France, Germany, Poland, Italy
09/09/2026
Phase II
Kymera Therapeutics Inc.
Immune System Diseases
Austria, Germany, Belgium, Romania, Italy, Slovakia, Poland, Spain
09/09/2026
Phase I
Ideaya Biosciences Inc.
Diagnosis
Spain, France
08/09/2026
Phase I
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
2025-523601-16-00Lymphoma, Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Foll…
Eli Lilly & Co.
Hemic and Lymphatic Diseases
Spain, Poland, Italy, France, Germany
08/09/2026
Phase III
Amgen Inc.
Neoplasms
Romania, Poland, Germany, Greece, Netherlands, Hungary, Portugal, France, Belgium, Italy, Spain
08/09/2026
Phase IV
Recordati AG
Hormonal diseases
Germany, Bulgaria, France, Romania, Italy, Poland, Spain
08/09/2026
Phase I/II
Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Immune System Diseases
Spain
08/09/2026
Phase III
Spur Therapeutics Limited
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Spain, Portugal
08/09/2026
Phase I
A clinical trial to learn about the effects of 225Ac-ETN029 in people with advanced solid tumors
2024-519111-34-00Small Cell Lung Cancer (SCLC), Neuroendocrine Prostate Canc…
Novartis Pharma AG
Neoplasms
France, Spain, Italy, Germany
08/09/2026
Phase II
Argenx
Immune System Diseases
Germany, Estonia, Lithuania, Portugal, Slovakia, Hungary, Romania, Poland, Spain, Austria, Belgium, France, Bulgaria
08/09/2026
Phase I
Study of GS-2426 in Participants With Advanced Solid Tumors
2026-526264-20-00MTAP-Deleted Advanced Solid Tumors
Gilead Sciences Inc.
Neoplasms
Spain
07/09/2026
Phase I
F. Hoffmann-La Roche AG
Neoplasms
Spain, Poland, Romania, Hungary, Germany, Italy, Belgium, Netherlands, Denmark, France
07/09/2026
Phase III
Sanofi-Aventis Recherche & Developpement
Immune System Diseases
Belgium, Czechia, Hungary, Sweden, Lithuania, Croatia, Netherlands, Slovakia, Poland, Austria, Norway, France, Italy, Bulgaria, Spain, Germany, Romania, Slovenia, Estonia, Portugal, Greece, Denmark
02/09/2026
Phase II
Dompe' Farmaceutici S.p.A.
Eye Diseases
Denmark, Italy, Germany, Hungary, Netherlands, Spain, Belgium, France, Portugal
01/09/2026
Phase II
Vanqua Bio Inc.
Nervous System Diseases
Netherlands, France, Spain, Germany
01/09/2026
Phase III
Vaderis Therapeutics AG
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hungary, Netherlands, Germany, Bulgaria, France, Italy, Lithuania, Spain, Belgium
31/08/2026
Phase II
Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Hemic and Lymphatic Diseases
Czechia, Denmark, Croatia, Spain, Sweden, Finland, Portugal, Ireland, Netherlands, Belgium, Norway
31/08/2026
Phase IV
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Nervous System Diseases
Spain
31/08/2026
Phase II
Novo Nordisk A/S
Nutritional and Metabolic Diseases
Spain, Hungary, Romania, Slovakia, Poland, Germany
31/08/2026
Phase III
F. Hoffmann-La Roche AG
Neoplasms
France, Spain, Austria, Greece, Portugal, Ireland, Belgium, Italy, Poland, Germany, Netherlands
28/08/2026
Phase I
An Open-Label Study of IDE034 in Adult Participants with Locally Advanced/Metastatic Solid Tumors
2026-526299-21-00Locally Advanced/Metastatic Solid Tumors -non-small cell l…
Ideaya Biosciences Inc.
Female Urogenital Diseases and Pregnancy Complications
Spain
28/08/2026
Phase I/II
Institut De Recherches Internationales Servier IRIS
Neoplasms
Netherlands, Spain, Germany, Italy, France, Finland
27/08/2026
Phase II
Contineum Therapeutics Inc.
Respiratory Tract Diseases
Italy, Belgium, Denmark, Austria, Greece, Germany, France, Netherlands, Portugal, Poland, Spain
26/08/2026
Phase II
Pfizer Inc.
Neoplasms
Spain, France, Italy, Ireland, Germany, Poland
26/08/2026
Phase II
Genmab A/S
Neoplasms
Italy, Belgium, France, Spain, Denmark, Netherlands, Germany
26/08/2026
Phase II
Instituto De Investigacion En Ciencias De La Salud Germans Trias I Pujol
Hormonal diseases
Spain
26/08/2026
Phase I
Laboratorios Normon S.A.
Not possible to specify
Spain
26/08/2026
Phase I
A Phase 1 Study of CTIM-76 in Patients with Recurring Ovarian Cancer and Other Advanced Solid Tumors
2025-523968-20-00Patients with Recurring Ovarian Cancer and Other Advanced S…
Context Therapeutics Inc.
Neoplasms
France, Spain
25/08/2026
Phase III
UCB Biopharma
Immune System Diseases
Hungary, France, Greece, Poland, Spain, Italy, Germany
25/08/2026
Phase III
Harmony Biosciences Management Inc.
Nervous System Diseases
Belgium, Italy, Germany, France, Spain, Poland
25/08/2026
Phase II
Apollo Therapeutics Limited
Skin and Connective Tissue Diseases
Hungary, Czechia, Germany, Bulgaria, Poland, Spain
25/08/2026
Phase II
Bristol-Myers Squibb Services Unlimited Company
Neoplasms
Greece, Hungary, Poland, Belgium, Spain, Netherlands, Germany, France, Portugal, Italy, Romania
25/08/2026
Phase I
TOLREMO therapeutics AG
Neoplasms
Italy, Spain
24/08/2026
Phase III
Dra. Elena González Guerra
Skin and Connective Tissue Diseases
Spain
24/08/2026
Phase III
Laboratorios Farmaceuticos Rovi S.A.
Neoplasms
Romania, Spain, Bulgaria, Czechia, Latvia, Poland, Croatia, Slovakia
21/08/2026
Phase III
Deciphera Pharmaceuticals Inc.
Hemic and Lymphatic Diseases
Austria, Czechia, Italy, Portugal, Germany, France, Hungary, Spain, Poland
21/08/2026
Phase III
Glaxosmithkline Research & Development Limited
Neoplasms
Italy, Portugal, Germany, Sweden, Poland, Romania, Finland, Greece, Norway, Spain, Netherlands, France, Hungary
21/08/2026
Phase III
K-Group Beta Inc.
Neoplasms
Germany, Spain, Italy, Belgium, Poland, France, Ireland
21/08/2026
Phase III
Regeneron Pharmaceuticals Inc.
Neoplasms
Italy, Spain, Poland, France, Norway, Greece, Germany
20/08/2026
Phase I
Janux Therapeutics Inc.
Neoplasms
Spain
19/08/2026
Phase I/II
Terremoto Biosciences Inc.
Neoplasms
Spain, Ireland, Hungary, Romania, France, Portugal, Belgium, Poland
18/08/2026
Phase III
UCB Biopharma
Immune System Diseases
Hungary, Greece, Italy, Spain, Germany, Poland, France
18/08/2026
Phase II
Sanofi-Aventis Recherche & Developpement
Nervous System Diseases
Spain, Germany
18/08/2026
Phase III
Amgen Inc.
Eye Diseases
Slovakia, Latvia, Czechia, Poland, Spain, Hungary, Lithuania
17/08/2026
Phase I
Novartis Pharma AG
Neoplasms
France, Italy, Spain, Germany
17/08/2026
Phase II
Sinfatin S.L.
Nervous System Diseases
Spain
17/08/2026
Phase III
Pfizer Inc.
Bacterial Infections and Mycoses
Spain, Finland, Poland, Germany, Greece, Hungary, Italy
17/08/2026
Phase I/II
Glaxosmithkline Research & Development Limited
Neoplasms
Italy, Germany, Spain, Finland, France
17/08/2026
Phase III
BioNTech SE
Male Urogenital Diseases
Belgium, Spain, Italy, Poland, Germany, Hungary
17/08/2026
Phase II
Cardurion Pharmaceuticals Inc.
Cardiovascular Diseases
Latvia, Slovakia, Lithuania, Hungary, Italy, Netherlands, Spain, Poland, Bulgaria, Czechia
14/08/2026
Phase III
Amgen Inc.
Hemic and Lymphatic Diseases
Spain, Hungary, Germany
14/08/2026
Phase II
Alianza Multidisciplinar Para La Investigacion De Los Tumores Genitourinarios Guard
Male Urogenital Diseases
Spain
14/08/2026
Phase II
Medica Scientia Innovation Research S.L.
Neoplasms
Spain, Italy, Germany
13/08/2026
Phase IV
Regeneron Pharmaceuticals Inc.
Respiratory Tract Diseases
Belgium, Italy, Spain
13/08/2026
Phase I
Exelixis Inc.
Neoplasms
Italy, Netherlands, France, Spain
11/08/2026
Phase I
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
2025-522532-14-00Advanced solid tumors
Pfizer Inc.
Neoplasms
Netherlands, France, Spain
11/08/2026
Phase I/II
Laboratorios Alter S.A.
Mental Disorders
Spain
11/08/2026
Phase I
Incyte Corp.
Neoplasms
Italy, Belgium, Germany, France, Spain
10/08/2026
Phase II
Sinfatin S.L.
Nervous System Diseases
Spain
10/08/2026
Phase I
Genmab A/S
Neoplasms
Spain, France
10/08/2026
Phase III
Novo Nordisk A/S
Nutritional and Metabolic Diseases
Netherlands, Belgium, Greece, Poland, Spain, Denmark, France, Bulgaria, Sweden
10/08/2026
Phase III
Argenx
Hormonal diseases
Italy, Czechia, Spain, Denmark, Belgium, Romania, Latvia, France, Germany, Greece, Sweden, Poland, Lithuania, Bulgaria
07/08/2026
Phase IV
HORUS-Cytomegalovirus Open Proof-of-concept Exploratory trial
2025-524845-28-00Cytomegalovirus infection in solid-organ transplant recipie…
Centre Hospitalier Universitaire Vaudois
Virus Diseases
France, Spain
07/08/2026
Phase IV
Gentofte Hospital, Moderna Inc.
Virus Diseases
Denmark, Spain
07/08/2026
Phase IV
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Virus Diseases
Spain
06/08/2026
Phase IV
Instituto De Investigacion Marques De Valdecilla
Virus Diseases
Spain
06/08/2026
Phase I/II
Orion Corporation
Neoplasms
Spain
06/08/2026
Phase II
AstraZeneca AB
Respiratory Tract Diseases
Poland, Hungary, Netherlands, Germany, Spain, Greece, Bulgaria, Italy, France, Denmark
04/08/2026
Phase I
Oryzon Genomics S.A.
Not possible to specify
Spain
04/08/2026
Phase I
Sumitomo Pharma America Inc.
Neoplasms
Spain, Bulgaria, Poland, Romania
04/08/2026
Phase III
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Skin and Connective Tissue Diseases
Denmark, Hungary, Sweden, Netherlands, Germany, Belgium, France, Greece, Norway, Finland, Czechia, Portugal, Bulgaria, Spain, Austria, Romania, Croatia, Poland, Estonia, Italy, Lithuania
03/08/2026
Phase III
Janssen Cilag International
Immune System Diseases
Norway, Romania, Austria, Italy, Slovakia, Germany, Hungary, Netherlands, Belgium, France, Portugal, Czechia, Poland, Spain, Greece
03/08/2026
Phase III
Janssen Cilag International
Immune System Diseases
France, Bulgaria, Romania, Slovakia, Norway, Denmark, Greece, Italy, Austria, Poland, Netherlands, Czechia, Germany, Belgium, Spain, Hungary, Portugal
03/08/2026
Phase I
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Neoplasms
Spain, Germany
31/07/2026
Phase III
AstraZeneca AB
Cardiovascular Diseases
Spain, Hungary, Germany, Poland, Italy, Bulgaria, Netherlands, Austria, Romania, Sweden, France, Greece, Slovakia, Czechia
29/07/2026
Phase II
Puma Biotechnology Inc.
Neoplasms
France, Poland, Spain
28/07/2026
Phase IV
Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz
Cardiovascular Diseases
Spain, Norway
28/07/2026
Phase I
A Phase 1 Study of PRT12396 in Participants with Select Myeloproliferative Neoplasms
2026-525484-40-00Post-Essential Thrombocythemia Myelofibrosis, Post-Polycyth…
Prelude Therapeutics Inc.
Neoplasms
Italy, France, Spain
27/07/2026
Phase II
Cancer Research UK
Neoplasms
Spain, France, Germany, Norway
27/07/2026
Phase III
Novo Nordisk A/S
Nutritional and Metabolic Diseases
Greece, Portugal, France, Slovakia, Bulgaria, Netherlands, Romania, Italy, Austria, Poland, Hungary, Spain, Czechia, Belgium
27/07/2026
Phase III
AbbVie Deutschland GmbH & Co. KG
Neoplasms
Italy, Greece, Spain, Belgium, France, Austria, Germany
27/07/2026
Phase III
Milestone Pharmaceuticals Inc.
Cardiovascular Diseases
Netherlands, Spain
27/07/2026
Phase III
AstraZeneca AB
Nutritional and Metabolic Diseases
Spain, Germany, Italy, Poland
27/07/2026
Phase III
Biogen Idec Research Limited
Nervous System Diseases
Finland, Spain, Italy, Poland, Ireland, Germany, France
24/07/2026
Phase III
AstraZeneca AB
Cardiovascular Diseases
Czechia, Italy, Hungary, Romania, Bulgaria, Sweden, Denmark, Poland, Spain, Norway, Finland, Greece, France, Germany
24/07/2026
Phase II
Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH
Digestive System Diseases
Germany, Spain
23/07/2026
Phase III
Neurocrine Biosciences Inc.
Hormonal diseases
Czechia, Germany, Sweden, Portugal, Romania, Bulgaria, Italy, Austria, Spain, Belgium
23/07/2026
Phase III
Chemo Research S.L.
Not possible to specify
Sweden, Czechia, Spain, Hungary, Poland, Finland, Romania
23/07/2026
Phase III
Skyhawk Therapeutics Inc.
Nervous System Diseases
Germany, Spain
23/07/2026
Phase I/II
Triana Biomedicines Inc.
Respiratory Tract Diseases
France, Italy, Germany, Spain
22/07/2026
Phase IV
Real-World Effectiveness of the Adjuvanted RSVPreF3 Vaccine in Adults ≥60 Years: A Pragmatic Randomized Trial (BronquiVal)
2026-526804-59-00Respiratory syncytial virus infection–related respiratory d…
Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Respiratory Tract Diseases
Spain
22/07/2026
Phase III
Colchicine for the Reduction of Dependency and Vascular Events after an Acute Intracerebral Hemorrhage (CoVasc-ICH2)
2025-523435-18-00Major cardiovascular events (MACE), spontaneous intracerebr…
Hamilton Health Sciences Corporation, PHRI Population Health Research Institute International
Cardiovascular Diseases
Spain, Belgium
22/07/2026
Phase II
Vall D Hebron Institute Of Oncology
Neoplasms
Spain
22/07/2026
Phase I
Tarlatamab Before and After Surgery for Recurrent High-Grade Glioma
2025-524359-30-00surgically resectable recurrent high-grade glioma
Vall D Hebron Institute Of Oncology
Neoplasms
Spain
22/07/2026
Phase I/II
Bristol-Myers Squibb Services Unlimited Company
Immune System Diseases
Poland, Italy, Spain, Germany
22/07/2026
Phase II
Alnylam Pharmaceuticals Inc.
Nervous System Diseases
Italy, Netherlands, Spain, Germany, Ireland
22/07/2026
Phase I
Phase 1/1b Study of BMS-986463 in Advanced Malignant Tumors
2025-523067-38-01Advanced Malignant Tumors; High-grade Serous Ovarian Carcin…
Bristol-Myers Squibb Services Unlimited Company
Neoplasms
Spain, France, Italy
21/07/2026
Phase III
Ipsen Bioscience Inc.
Digestive System Diseases
Spain, Sweden, Germany, Romania, Finland, Portugal, Austria, Italy, Denmark, Czechia, France, Netherlands, Poland, Belgium, Norway
21/07/2026
Phase I/II
Glaxosmithkline Research & Development Limited
Neoplasms
Netherlands, France, Spain
21/07/2026
Phase I
Study of MX006 in Patients With Advanced and/or Metastatic Tumors known to express B7-H3
2025-524929-41-00Advanced Solid Tumor Types Known to Express B7-H3
Myricx Pharma Limited
Neoplasms
Spain
20/07/2026
Phase III
Novartis Pharma AG
Nervous System Diseases
Norway, Poland, Spain, Sweden, Bulgaria, Netherlands, Finland, Portugal, Austria, Italy, Greece, Ireland, Czechia, France, Romania, Belgium, Germany, Denmark, Slovakia, Hungary
20/07/2026
Phase III
Alkermes Inc.
Nervous System Diseases
Sweden, Finland, Belgium, Spain, Austria, Netherlands, France, Norway, Germany, Italy, Poland
20/07/2026
Phase III
Elpida Therapeutics SPC
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Spain
17/07/2026
Phase II
Tectonic Operating Company Inc.
Cardiovascular Diseases
Poland, Romania, Spain
17/07/2026
Phase I
Laboratorios Alter S.A.
Nutritional and Metabolic Diseases
Spain
17/07/2026
Phase III
Merck Healthcare KGaA
Neoplasms
Belgium, Germany, France, Denmark, Poland, Spain, Netherlands, Italy, Austria
14/07/2026
Phase III
Apellis Pharmaceuticals Inc.
Female Urogenital Diseases and Pregnancy Complications
France, Portugal, Spain, Slovakia, Italy, Germany, Poland
14/07/2026
Phase III
Revolution Medicines Inc.
Digestive System Diseases
Poland, Belgium, Norway, Sweden, Austria, Germany, Denmark, Netherlands, France, Italy, Spain
14/07/2026
Phase II
AstraZeneca AB
Immune System Diseases
France, Germany, Italy, Belgium, Poland, Spain
13/07/2026
Phase II
Recursion Pharmaceuticals Inc.
Neoplasms
Netherlands, Germany, Spain
13/07/2026
Phase IV
Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
Reproductive and Urinary Physiological Phenomena
Spain
13/07/2026
Phase I
A Phase 1, First-in-human, Dose Escalation Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
2026-525234-39-00Relapsed or Refractory higher-risk myelodysplastic syndrome…
Janssen Cilag International
Neoplasms
France, Spain, Germany, Denmark, Belgium
13/07/2026
Phase II
Goethe University Frankfurt
Virus Diseases
Germany, Spain
13/07/2026
Phase III
Spanish Society Of Cardiology
Cardiovascular Diseases
Spain
10/07/2026
Phase II
Elevar Therapeutics Inc.
Neoplasms
France, Spain
09/07/2026
Phase III
Institut Gustave Roussy
Neoplasms
Sweden, Poland, Denmark, Finland, Netherlands, Italy, France, Spain
08/07/2026
Phase II
Eisai Limited
Nervous System Diseases
Belgium, Italy, Spain, Germany
08/07/2026
Phase II
Bristol-Myers Squibb Services Unlimited Company
Neoplasms
Belgium, Ireland, Germany, Norway, Italy, France, Spain
07/07/2026
Phase III
AbbVie Deutschland GmbH & Co. KG
Neoplasms
Portugal, Spain, France, Italy, Germany, Austria
06/07/2026
Phase II
Mediar Therapeutics Inc.
Immune System Diseases
Netherlands, Romania, Poland, France, Italy, Spain
06/07/2026
Phase I
Glaxosmithkline Research & Development Limited
Bacterial Infections and Mycoses
Spain
06/07/2026
Phase III
Sanofi-Aventis Recherche & Developpement
Respiratory Tract Diseases
Denmark, Sweden, Poland, Estonia, Portugal, Latvia, Spain, Hungary, Germany, Finland, Italy, Belgium, France
06/07/2026
Phase III
Sanofi-Aventis Recherche & Developpement
Respiratory Tract Diseases
Germany, Romania, Greece, Norway, Netherlands, Poland, Lithuania, Czechia, Slovakia, Spain
06/07/2026
Phase III
University Of Oxford
Mental Disorders
Netherlands, Greece, Germany, Italy, Austria, Spain
01/07/2026
Phase I/II
Ideaya Biosciences Inc.
Neoplasms
France, Spain
01/07/2026
Phase III
Janssen Cilag International
Neoplasms
Poland, Spain, Czechia, France, Italy, Germany, Greece
01/07/2026
Phase I
AbbVie Deutschland GmbH & Co. KG
Immune System Diseases
Belgium, Netherlands, Spain, Germany, Italy
01/07/2026
Phase III
Genmab A/S
Neoplasms
Finland, Belgium, Hungary, France, Denmark, Austria, Germany, Italy, Spain, Czechia, Norway, Poland
01/07/2026
Phase I/II
Krystal Biotech Inc.
Neoplasms
France, Spain
30/06/2026
Phase III
Nuvation Bio Inc.
Respiratory Tract Diseases
Spain, Belgium, France, Italy, Germany
30/06/2026
Phase III
Insmed Inc.
Respiratory Tract Diseases
Greece, France, Italy, Belgium, Denmark, Germany, Poland, Czechia, Portugal, Austria, Spain, Romania
30/06/2026
Phase I/II
Ionis Pharmaceuticals Inc.
Nervous System Diseases
Spain, France, Belgium, Portugal, Germany
30/06/2026
Phase III
Renaissance Pharma Limited
Nervous System Diseases
France, Spain, Denmark, Ireland, Germany
30/06/2026
Phase I
Allinky Biopharma S.L.
Not possible to specify
Spain
29/06/2026
Phase III
Merck Healthcare KGaA
Skin and Connective Tissue Diseases
Germany, Romania, France, Bulgaria, Belgium, Spain, Poland, Greece, Italy, Czechia
29/06/2026
Phase III
Merck Healthcare KGaA
Immune System Diseases
Spain, Belgium, France, Germany, Slovakia, Romania, Bulgaria, Italy, Poland, Greece
29/06/2026
Phase IV
Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre
Nutritional and Metabolic Diseases
Spain
29/06/2026
Phase I/II
Revolution Medicines Inc.
Neoplasms
France, Poland, Ireland, Spain, Greece, Germany, Italy, Sweden, Belgium
29/06/2026
Phase III
Incyte Corp.
Neoplasms
Poland, Italy, Netherlands, Sweden, Denmark, Finland, Spain, France, Germany, Belgium, Norway, Austria
26/06/2026
Phase II
Probelte Pharma S.L.
Disorders of Environmental Origin
Spain
26/06/2026
Phase IV
Santiago Dexeus Font Fundacio Privada
Female Urogenital Diseases and Pregnancy Complications
Spain
23/06/2026
Phase II
Sanofi-Aventis Recherche & Developpement
Respiratory Tract Diseases
Poland, Spain, France, Netherlands, Germany
23/06/2026
Phase IV
Hospital Universitario Rio Hortega
Respiratory Tract Diseases
Spain
23/06/2026
Phase III
Adarx Pharmaceuticals Inc.
Immune System Diseases
Poland, Italy, Hungary, France, Austria, Czechia, Belgium, Spain, Bulgaria, Germany, Croatia
22/06/2026
Phase III
Zenas Biopharma (USA) LLC
Nervous System Diseases
Germany, Bulgaria, Netherlands, Sweden, Portugal, Croatia, Italy, Austria, Spain, Poland, France, Denmark, Hungary, Romania, Estonia, Slovakia, Belgium, Czechia, Norway, Lithuania, Greece, Slovenia
22/06/2026
Phase II
Astellas Pharma Global Development Inc.
Neoplasms
Germany, France, Poland, Italy, Spain
22/06/2026
Phase II
Takeda Development Center Americas Inc.
Nervous System Diseases
Spain, Italy, France
22/06/2026
Phase III
Daiichi Sankyo Europe GmbH
Cardiovascular Diseases
Italy, Spain, Germany
22/06/2026
Phase I
Biocon Biologics UK PLC
Neoplasms
Spain, Romania
22/06/2026
Phase I
A Phase 1 first-in-human study to evaluate SAR448272 in adult participants
2026-526014-87-00immunological diseases, healthy volunteers
Sanofi-Aventis Recherche & Developpement
Immune System Diseases
Germany, Czechia, France, Spain, Italy
19/06/2026
Phase IV
Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Nutritional and Metabolic Diseases
Spain
19/06/2026
Phase I/II
Iecure Inc.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Spain, France, Slovenia
18/06/2026
Phase I
Phase 1/1b Study of RNDO-564 in Participants with Advanced Urothelial Cancer
2025-524687-38-00Other Solid Tumors Associated with Nectin-4 Expression, Rel…
Rondo Therapeutics Inc.
Neoplasms
Spain
17/06/2026
Phase III
Bristol-Myers Squibb Services Unlimited Company
Respiratory Tract Diseases
Finland, Portugal, Hungary, Ireland, Poland, Greece, France, Belgium, Denmark, Italy, Spain, Netherlands, Austria, Germany
17/06/2026
Phase II
Galderma S.A.
Skin and Connective Tissue Diseases
Poland, Italy, Bulgaria, France, Greece, Spain, Croatia
17/06/2026
Phase I
Theras Inc.
Neoplasms
Spain, Italy, France
16/06/2026
Phase II
Spyre Therapeutics Inc.
Digestive System Diseases
Croatia, Poland, Austria, Czechia, Italy, Slovakia, Bulgaria, Greece, Belgium, Spain, Hungary, Germany, Lithuania, France, Romania
16/06/2026
Phase III
Sanofi-Aventis Recherche & Developpement
Musculoskeletal Diseases
France, Netherlands, Germany, Czechia, Belgium, Austria, Hungary, Greece, Spain
15/06/2026
Phase IV
Swedish Orphan Biovitrum AB (publ)
Immune System Diseases
France, Italy, Spain, Germany, Austria, Belgium, Czechia
15/06/2026
Phase III
Merck Sharp & Dohme LLC
Neoplasms
Greece, Netherlands, Sweden, France, Italy, Spain, Denmark
12/06/2026
Phase III
Glaxosmithkline Research & Development Limited
Nutritional and Metabolic Diseases
Greece, Germany, Belgium, Netherlands, Poland, Italy, France, Spain, Bulgaria, Austria
12/06/2026
Phase I/II
Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz
Immune System Diseases
Spain
11/06/2026
Phase III
Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre
Otorhinolaryngologic Diseases
Spain
11/06/2026
Phase III
Astellas Pharma Global Development Inc.
Neoplasms
Germany, Italy, Spain, Poland, France
10/06/2026
Phase III
Merck Sharp & Dohme LLC
Neoplasms
France, Spain, Germany, Greece, Italy, Poland
09/06/2026
Phase I/II
Verastem Inc.
Neoplasms
Italy, France, Germany, Belgium, Spain, Netherlands
09/06/2026
Phase III
Kardigan Inc.
Cardiovascular Diseases
Norway, Czechia, Portugal, Austria, Poland, France, Spain
08/06/2026
Phase I/II
Merck Sharp & Dohme LLC
Neoplasms
Germany, Poland, Greece, Italy, France, Spain
08/06/2026
Phase II
Novartis Pharma AG
Skin and Connective Tissue Diseases
Germany, Spain, Netherlands, France, Italy
08/06/2026
Phase III
Fundacion Para La Investigacion Biomedica Hospital Infantil Universitario Nino Jesus
Bacterial Infections and Mycoses
Spain
08/06/2026
Phase III
Fundacion Biomedica Galicia Sur
Digestive System Diseases
Spain
08/06/2026
Phase I/II
Medica Scientia Innovation Research S.L.
Neoplasms
Spain
08/06/2026
Phase III
Zai Lab (US) LLC
Neoplasms
Belgium, Czechia, Germany, Denmark, Greece, Netherlands, Poland, Spain, Austria, Italy, France, Croatia, Romania, Norway
08/06/2026
Phase II
Pfizer Inc.
Respiratory Tract Diseases
Spain, Germany, Poland, Czechia, Greece, Italy, Bulgaria, France, Hungary
08/06/2026
Phase I
Bayer Consumer Care AG
Neoplasms
Finland, Spain, Sweden, Italy, Denmark, Netherlands, Belgium
08/06/2026
Phase II
Hospital Universitario 12 De Octubre
Behavioral Disciplines and Activities
Spain
08/06/2026
Phase III
Eyebiotech Limited
Eye Diseases
Austria, Slovakia, Portugal, Czechia, Hungary, Spain, France, Denmark, Italy, Croatia
05/06/2026
Phase III
Alkermes Inc.
Nervous System Diseases
Spain, Netherlands, Belgium, Italy, France, Austria, Czechia, Germany, Sweden, Poland
04/06/2026
Phase I/II
Nura Bio Inc.
Nervous System Diseases
Poland, Netherlands, Italy, Spain
03/06/2026
Phase III
Alkermes Inc.
Nervous System Diseases
Italy, France, Netherlands, Spain, Belgium, Austria, Czechia, Finland, Germany, Sweden, Norway, Poland
02/06/2026
Phase III
F. Hoffmann-La Roche AG
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
France, Austria, Poland, Netherlands, Spain, Denmark, Italy, Germany, Hungary
01/06/2026
Phase III
Inmunotek S.L.
Immune System Diseases
Spain
01/06/2026
Phase III
F. Hoffmann-La Roche AG
Hemic and Lymphatic Diseases
Hungary, Spain, Ireland, Poland, Austria, Germany, Denmark, Belgium, Netherlands, Italy, France
01/06/2026
Phase II
Grupo Espanol De Leucemia Mieloide Cronica (GELMC)
Neoplasms
Spain
01/06/2026
Phase III
Innocare Pharma Inc.
Neoplasms
Poland, France, Czechia, Spain, Romania
01/06/2026
Phase I/II
Somagenetix AG
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Germany, Spain
29/05/2026
Phase II
Centre Hospitalier De Versailles
Hemic and Lymphatic Diseases
Germany, France, Czechia, Netherlands, Spain
29/05/2026
Phase III
Novartis Pharma AG
Neoplasms
Belgium, Germany, Austria, Poland, Spain, Italy, Netherlands, Czechia, France
29/05/2026
Phase II
Vertex Pharmaceuticals Inc.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Spain, Sweden, Germany, Italy, Belgium, Czechia, Ireland, Portugal, Netherlands, France, Denmark
29/05/2026
Phase II
Tyra Biosciences Inc.
Neoplasms
Bulgaria, France, Spain
28/05/2026
Phase I/II
Merck Sharp & Dohme LLC
Neoplasms
Poland, Italy, France, Germany, Spain
28/05/2026
Phase I/II
Novartis Pharma AG
Neoplasms
Spain, France
27/05/2026
Phase II
F. Hoffmann-La Roche AG
Immune System Phenomena
Italy, Spain, Germany, France, Denmark, Poland, Belgium
27/05/2026
Phase III
Janssen Cilag International
Immune System Diseases
Slovakia, Germany, Denmark, France, Spain, Italy, Netherlands, Belgium, Poland, Sweden, Austria, Czechia, Hungary
27/05/2026
Phase III
Solid Biosciences Inc.
Musculoskeletal Diseases
Spain, Netherlands, France, Italy, Belgium, Germany
26/05/2026
Phase I/II
Merck Sharp & Dohme LLC
Neoplasms
France, Spain, Sweden, Germany, Italy, Belgium, Denmark, Czechia, Hungary, Netherlands, Slovakia
26/05/2026
Phase III
Generate Biomedicines Inc.
Respiratory Tract Diseases
Italy, Slovakia, Spain, Ireland, Belgium, France, Estonia
26/05/2026
Phase III
Inmunotek S.L.
Immune System Diseases
Spain
25/05/2026
Phase II
C4 Therapeutics Inc.
Hemic and Lymphatic Diseases
Italy, France, Spain, Poland
25/05/2026
Phase I
Merida Biosciences Inc.
Immune System Diseases
Spain
22/05/2026
Phase III
Bristol-Myers Squibb Services Unlimited Company
Neoplasms
France, Ireland, Germany, Greece, Bulgaria, Spain, Netherlands, Italy, Sweden, Romania, Hungary, Belgium, Austria, Poland
22/05/2026
Phase I/II
Orion Corporation
Neoplasms
Finland, Denmark, Spain, France
22/05/2026
Phase II
Eikon Therapeutics Inc.
Neoplasms
Germany, Spain, Netherlands, Romania, Greece, Italy, Austria, Belgium, Bulgaria, France, Hungary, Poland
21/05/2026
Phase II
Pharming Technologies B.V.
Metabolism
Belgium, Germany, Czechia, Spain, Denmark, Italy, France, Netherlands
21/05/2026
Phase I
Glaxosmithkline Research & Development Limited
Neoplasms
Spain, Denmark, Finland, France
21/05/2026
Phase III
Novartis Pharma AG
Skin and Connective Tissue Diseases
Germany, Spain, France, Poland, Bulgaria, Czechia
20/05/2026
Phase III
Novartis Pharma AG
Immune System Diseases
Portugal, Greece, Germany, Hungary, France, Spain, Bulgaria, Slovakia, Poland, Czechia, Belgium, Italy, Romania, Denmark
20/05/2026
Phase III
Avidity Biosciences Inc.
Musculoskeletal Diseases
Italy, Germany, France, Spain, Belgium, Poland, Netherlands
20/05/2026
Phase III
Alianza Multidisciplinar Para La Investigacion De Los Tumores Genitourinarios Guard
Neoplasms
Spain, Germany, France, Portugal, Italy
19/05/2026
Phase III
VarmX B.V.
Hemic and Lymphatic Diseases
Belgium, Germany, Italy, France, Czechia, Bulgaria, Hungary, Spain, Netherlands, Poland, Austria, Estonia, Romania, Portugal, Lithuania
19/05/2026
Phase II
Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.
Nutritional and Metabolic Diseases
Portugal, Greece, Italy, Poland, Estonia, Slovakia, Sweden, Denmark, Belgium, Norway, Romania, France, Spain, Germany, Netherlands, Croatia
19/05/2026
Phase II
A Phase II Study of Naxitamab Added to Induction Therapy for Subjects with Newly Diagnosed High-Risk Neuroblastoma
2025-524140-35-00Neuroblastoma or ganglioneuroblastoma (nodular or intermixe…
Fundacio Sant Joan De Deu
Neoplasms
Spain
19/05/2026
Rows per page Showing 1–500 of 1064
1 2 3 Next
Cite this view

Priya Life Science (2026). EU Clinical Trials Register (CTIS), filtered. Derived from the EMA Clinical Trials Information System. Retrieved 21 November 2026. https://priyalifescience.com/clinical-trials-europe/country/spain

Query this register directly
GET /api/export.php?register=trials-eu&format=json Try it now →

About this register

This register is built from the EU Clinical Trials Information System (CTIS), run by the European Medicines Agency: the single register for every trial authorised under the EU Clinical Trials Regulation (536/2014). CTIS held 12,905 trial records at the last sync on 21 Nov 2026, 03:17 UTC; this register shows the 2,554 most recently authorised of them, a stated recency window rather than the full archive. The list can be downloaded as CSV or JSON.

This page shows the 1,064 of those trials with a site in Spain.

How many recently authorised EU trials have a site in Spain?

1,064 of the 2,554 most recently authorised trials in this register list a site in Spain; 466 of them are Phase III. Trials are counted by authorisation on CTIS, not by recruitment status, which CTIS does not publish in the same form as ClinicalTrials.gov.

Summary by phase

Trials by phase (Spain), 1,064 trials
PhaseTrialsShare
Phase III46643.8%
Phase II27425.8%
Phase I14413.5%
Phase I/II12211.5%
Phase IV585.5%

Most active sponsors

Lead sponsors with the most trials (Spain)
Lead sponsorTrials
AstraZeneca AB45
Novartis Pharma AG38
Merck Sharp & Dohme LLC36
Pfizer Inc.31
F. Hoffmann-La Roche AG28
Glaxosmithkline Research & Development Limited26
Sanofi-Aventis Recherche & Developpement24
Eli Lilly & Co.22
Bristol-Myers Squibb Services Unlimited Company21
Janssen Cilag International20
Listing here is informational and not medical advice; eligibility is determined by each study team. Looking for Irish sites? See the Ireland, UK or USA registers. For approved medicines, see the EMA Approvals Tracker.